Imatinib Clinical Trials
16 recruitingDrug
Phase 28Phase 34Phase 42Phase 12
Showing 1–16 of 16 trials
Recruiting
Phase 2
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)222 enrolled141 locationsNCT06124157
Recruiting
Phase 3
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Leukemia, Acute Lymphoblastic
Mats Heyman6,430 enrolled139 locationsNCT04307576
Recruiting
Phase 1
Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
Gastrointestinal Stromal Tumors
University of California, San Diego18 enrolled1 locationNCT07171203
Recruiting
Phase 4
Asciminib Roll-over Study
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals347 enrolled84 locationsNCT04877522
Recruiting
Phase 2
Imatinib TDM in GIST
Gastrointestinal Stromal Tumors
Reema A. Patel28 enrolled1 locationNCT05493215
Recruiting
Phase 3
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.182 enrolled41 locationsNCT06682169
Recruiting
Phase 2
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage IVMelanoma Stage III
University of California, San Francisco25 enrolled2 locationsNCT04598009
Recruiting
Phase 2
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Chronic Phase Chronic Myelogenous Leukemia
Medical College of Wisconsin51 enrolled4 locationsNCT04838041
Recruiting
Phase 1
Imatinib and Trametinib for KRAS-mutated Solid Tumor
Solid Tumor Cancer
China Medical University Hospital10 enrolled1 locationNCT06962254
Recruiting
Phase 2
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Goethe University220 enrolled85 locationsNCT06061094
Recruiting
Phase 4
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Hematological Neoplasms
Wei Zhao1,500 enrolled2 locationsNCT03844360
Recruiting
Phase 2
Precision Cancer Therapy in Rare Cancers
Rare Malignant Neoplasm
Oslo University Hospital96 enrolled1 locationNCT06119789
Recruiting
Phase 3
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL.
Ph+ ALL
Ascentage Pharma Group Inc.350 enrolled14 locationsNCT06051409
Recruiting
Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707
Recruiting
Phase 2
Ma-Spore ALL 2020 Study
B Lymphoblastic Leukemia
National University Hospital, Singapore500 enrolled3 locationsNCT06336395
Recruiting
Phase 2
Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
First Affiliated Hospital of Zhejiang University122 enrolled1 locationNCT04933669